Literature DB >> 29769958

TB in Canada-The battle is not over.

G G Alvarez1,2,3.   

Abstract

Entities:  

Year:  2015        PMID： 29769958      PMCID： PMC5868680          DOI： 10.14745/ccdr.v41is2a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  9 in total

1.  Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

Authors:  M Elsa Villarino; Nigel A Scott; Stephen E Weis; Marc Weiner; Marcus B Conde; Brenda Jones; Sharon Nachman; Ricardo Oliveira; Ruth N Moro; Nong Shang; Stefan V Goldberg; Timothy R Sterling
Journal:  JAMA Pediatr       Date:  2015-03       Impact factor: 16.193

2.  Whole-genome sequencing and social-network analysis of a tuberculosis outbreak.

Authors:  Jennifer L Gardy; James C Johnston; Shannan J Ho Sui; Victoria J Cook; Lena Shah; Elizabeth Brodkin; Shirley Rempel; Richard Moore; Yongjun Zhao; Robert Holt; Richard Varhol; Inanc Birol; Marcus Lem; Meenu K Sharma; Kevin Elwood; Steven J M Jones; Fiona S L Brinkman; Robert C Brunham; Patrick Tang
Journal:  N Engl J Med       Date:  2011-02-24       Impact factor: 91.245

Review 3.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

4.  Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors:  Timothy R Sterling; M Elsa Villarino; Andrey S Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E Weis; Marc Weiner; Diane Wing; Marcus B Conde; Lorna Bozeman; C Robert Horsburgh; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

5.  Reemergence and amplification of tuberculosis in the Canadian arctic.

Authors:  Robyn S Lee; Nicolas Radomski; Jean-Francois Proulx; Jeremy Manry; Fiona McIntosh; Francine Desjardins; Hafid Soualhine; Pilar Domenech; Michael B Reed; Dick Menzies; Marcel A Behr
Journal:  J Infect Dis       Date:  2015-01-09       Impact factor: 5.226

6.  Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities.

Authors:  Richard Long; Vernon Hoeppner; Pamela Orr; Martha Ainslie; Malcolm King; Sylvia Abonyi; Maria Mayan; Dennis Kunimoto; Deanne Langlois-Klassen; Courtney Heffernan; Angela Lau; Dick Menzies
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

7.  The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.

Authors:  Gonzalo G Alvarez; Deborah D Van Dyk; Naomi Davies; Shawn D Aaron; D William Cameron; Marc Desjardins; Ranjeeta Mallick; Natan Obed; Maureen Baikie
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

8.  A summary of tuberculosis drug resistance in Canada, 2003-2013.

Authors:  M McGuire; V Gallant; A-C Bourgeois; S Ogunnaike-Cooke
Journal:  Can Commun Dis Rep       Date:  2015-03-19

9.  Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut.

Authors:  Gonzalo G Alvarez; Deborah D VanDyk; Shawn D Aaron; D William Cameron; Naomi Davies; Natasha Stephen; Ranjeeta Mallick; Franco Momoli; Katherine Moreau; Natan Obed; Maureen Baikie; Geraldine Osborne
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.